CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 8. Constitutive overexpression of murine JunD in a stable cell line results in an increase in p202 levels. Cells overexpressing JunD (Lanes 5–7) or control cells (transfected with vector; Lanes 2–4) were incubated in growth medium supplemented with 10% (Lanes 2 and 5) or 1% (Lanes 3, 4, 6, and 7) for 3 days. Cells incubated in 1% serum (Lanes 4 and 7) were also stimulated with 20% serum for 24 h. As a control, AKR-2B cells were treated with IFN for 48 h (Lane 1). Cells extracts were prepared as described in "Materials and Methods," and equal amounts of proteins were analyzed by immunoblotting using the anti-p202 antibody. An arrow indicates the p202 protein band.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation